1. ResearchAarkstore Enterprise U.S. Glucose Testing Markets
http://www.aarkstore.com/search/viewresults.asp?search=2012&PubId=&pagenum=1
http://www.aarkstore.com/search/viewresults.asp?search=Markets&PubId=&pagenum=1
http://www.aarkstore.com/search/viewresults.asp?search=Cancer%20&PubId=&pagenum=1
U.S. glucose testing is undergoing a significant transition, driven by new analytical technologies
and developments in diabetes treatment. Although the blood glucose testing segment of the in
vitro diagnostics (IVD) industry is mature, several segments of the market, such as home testing
devices for diabetes management and point of care (POC) instruments for use in professional
settings, will exhibit strong growth. Direct access testing has emerged as a strong force in the
blood glucose testing segment, and non-invasive and minimally-invasive testing now represent
major new areas for the application of IVD testing. This TriMark Publications report describes
the specific market segments for blood glucose testing and diabetes management in the U.S.
market. It reviews all of the generally-accepted clinical analytical methods that are currently in
use today for measuring serum, plasma or whole-blood glucose concentrations. Additionally,
this study examines clinical measurement devices, reagents and supplies as utilized in hospitals,
clinics, doctor’s offices and at-home care locations. Moreover, it analyzes almost all of the
companies known to be marketing, manufacturing or developing glucose testing products for
the U.S. market. Each company is discussed in extensive depth with a section on its history,
product line, business and marketing analysis, and a subjective commentary of the company's
market position. Detailed tables and charts with sales forecasts and market data are also
included.
Table of Contents :
1. Overview 11
1.1 Statement of Report 11
1.2 About this Report 11
1.3 Scope of the Report 12
1.4 Methodology 13
1.5 Executive Summary 14
2. Diabetes 16

2. 2.1 Demographics of Diabetes in the U.S. 17
2.2 Understanding the Metabolic Conditions Underlying and Associated with Diabetes 21
2.2.1 Pre-Diabetes Syndrome 23
2.2.2 Metabolic Syndrome 23
2.2.3 Progression of Diabetes 23
2.2.4 Diabetes and Inflammation 23
2.2.5 Risk Factors and Diabetes 24
2.2.5.1 Obesity 25
2.2.5.2 Stress-induced Hyperglycemia 27
2.2.6 Complications and Co-Morbidities in Diabetes 27
2.2.6.1 Preventing Complications and Co-Morbidities in Diabetes 30
2.2.6.2 Cardiovascular Disease Facts 32
2.3 Economics of Diabetes 36
3. Market Analysis: Size, Growth, Share and Competitors 42
3.1 U.S. Market 43
3.1.1 U.S. Over-the-Counter (OTC) Self-testing Glucose Market 44
3.1.2 U.S. Professional Glucose Testing Market 50
3.1.3 Continuous Glucose Monitoring Markets 51
3.2 Competitive Situation 51
3.2.1 Key Players 51
3.2.2 Analyses of the Current Market Conditions, Competition and Product Mix 52
3.3 Market Drivers and Restraints 55
3.3.1 Market Drivers 55
3.3.2 Market Restraints 56
3.4 Market and Product Trends 58

3. 3.4.1 Market Trends 59
3.4.2 Technology Trends 59
3.5 Strategic Recommendations 61
3.6 Competitive Strategies 62
3.7 Analysis of the Glucose Point of Care Market 64
3.8 Adjacent Markets 65
4. Glucose Diagnostic and Monitoring Recommendations 66
4.1 Diagnosis of Diabetes Mellitus 66
4.2 Tight Glucose Control in Treating Diabetes 67
For more information please visit link:
http://www.aarkstore.com/reports/U-S-Glucose-Testing-Markets-208195.html
Neel
Aarkstore Enterprise
Phone:08149852585
Email:enquiry@aarkstore.com
URL:www.aarkstore.com
http://www.facebook.com/aarkstoreenterprise
http://in.linkedin.com/in/aarkstore
Breast Cancer Therapies Markets
HIV-AIDS Testing Markets
Over-the-Counter Diagnostic Products World Markets
DNA Sequencing and PCR Markets
Medical Imaging Markets
Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business

4. Trends and Strategies
Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets
Diabetes, Metabolic Syndrome and Cardiovascular Disease
Catheter Markets
Blood Glucose Testing and Diabetes Management
Global Flow Cytometry Market
U.S. Glucose Testing Markets
High-Growth Diagnostic Testing Markets
European Point of Care Diagnostic Testing Markets
Disposable Syringe Markets
Point of Care Diagnostic Testing World Markets
Disposable Medical Supplies Markets
Molecular Diagnostics in Infectious Disease Testing
Companion Diagnostics in Personalized Medicine and Cancer Therapy
World Glucose Self-Testing Markets
Veterinary Health Markets
Point of Care Diagnostic Testing Sector Trends
Cardiac Marker Diagnostic Testing Markets
Mass Spectroscopy for Clinical Laboratory Analysis
Cardiac Rhythm Management Devices World Markets
Picture Archiving and Communications Systems (PACS)
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Cancer Diagnostic Testing World Markets
Positron Emission Tomography (PET) Markets
Molecular Diagnostics Markets
Molecular Diagnostics in Cancer Testing
Drugs of Abuse Testing Markets
Ultrasound Markets
Nuclear Cardiology Markets
Medical Imaging Bundle
Cancer Vaccines Markets
European Medical Imaging Markets
Respiratory Therapeutics and Devices Markets

5. Diagnostics Bundle
Mammography World Markets
India's In Vitro Diagnostic Testing Industry
Orthopedics Markets
Cell-Based Assays for Drug Discovery
Cytology and HPV Testing World Markets
Clinical Chemistry Analyzers
Clinical Immunoanalyzer Markets
Microscopy Markets
Automated Microbial Testing Markets
Anti-Infective Drugs Markets
Plastic Surgery Markets